Derivatives of quinuclidine n-oxide as muscarinic receptor ligands
US5675007A · kind A · utility
2Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 1996 |
| Grant date | Oct 7, 1997 |
| Priority date | — |
| Expiry date | Nov 12, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I) or a pharmaceutically acceptable salt thereof (I) wherein R.sub.1 represents (a), R.sub.2 is a group OCH.sub.3, and R.sub.3 is cyano, for use in the treatment and/or prophylaxis of dementia in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.